There was a report on NWBO a while back that suggested 2017/2018 for approval and major ramp up I believe. NWBO was projected to have a very rapid growth pace as well. Near the top of all biotechs if I remember right. This report was stickied but has since been removed. It was from Evaluate Pharma in 2014. Best wishes.